侵蚀性食道炎的试验性药物:临床开发管道中有什么?
Daniel Martin Simadibrata1,2,3, Elvira Lesmana2,3, Yeong Yeh Lee4,5
1Department of Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Expert opinion on investigational drugs
|August 17, 2024
概括
竞争性酸阻断剂 (PCAB) 显示出治疗侵蚀性食道炎 (EE) 的前景,特别是对质子抑制剂 (PPI) 无反应的严重病例. 需要进一步的试验来确认PCAB优于PPI.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
背景情况:
- 质子抑制剂 (PPI) 是侵蚀性食道炎 (EE) 的标准药物.
- 很大一部分患者,特别是严重的EE (洛杉矶C级/D级),对PPI反应不佳.
- 新型治疗药物正在探索,以管理耐火性EE.
研究的目的:
- 审查EE治疗的新兴药物.
- 突出竞争性酸阻断剂 (PCAB) 作为 PPI 的替代品的潜力.
主要方法:
- 对EE新药的文献审查.
- 对研究粘膜保护剂, prokinetics,TLESR减速剂,新型 PPI 和 PCAB 的研究进行分析.
- 专注于PCAB与PPI相比的有效性和安全性数据.
主要成果:
- 竞争性酸阻断剂 (PCAB) 在EE治疗中显示出有前途的疗效和安全性.
- PCABs,特别是Vonoprazan,显示出比PPI的潜在优势,特别是在严重的EE病例中.
- PCABs的药理动力学和药理动力学特性似乎优于PPI.
结论:
- PCABs代表了一种有前途的新类药物用于EE治疗.
- 进一步的随机对照试验对于验证PCABs对PPI的优越性至关重要.
- PCABs可能为患有严重或PPI耐药的EE患者提供更有效的治疗选择.
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
62
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
62
Barrett Esophagus-II: Clinical Manifestations and Management
131
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
131
Peptic Ulcer Disease IV: Management
78
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
377
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
377
Esophageal Strictures-II: Clinical Features and Management
57
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
57
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
361
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
361


